Pharma Industry News

information-analysis-insights

  • Home
  • Directories
  • Reports
  • Know Us
  • News
    • New Projects
    • New Launches
    • Formulations
    • Insights
    • New Drugs
    • BioTechnology
    • Ayurvedic Drugs

Alembic

Alembic Pharma receives USFDA approval for travopost ophthalmic solution

January 3, 2020 IbisResearch 0

Alembic Pharmaceuticals has received final USFDA approval for its abbreviated new drug application (ANDA) travoprost ophthalmic solution USP, 0.004%. The approved ANDA is therapeutically equivalent […]

Alembic Pharma receives USFDA approval for Desonide ointment

November 10, 2019 IbisResearch 0

Alembic Pharmaceuticals through its joint venture firm Aleor Dermaceuticals has received USFDA approval for Desonide Ointment. The Desonide Ointment with a strength of 0.05 per […]

Alembic Pharma receives USFDA approval for clobetasol propionate

October 19, 2019 IbisResearch 0

Alembic Pharmaceuticals through its joint venture (JV) firm Aleor Dermaceuticals has received final USFDA approval for Clobetasol Propionate spray, used to treat plaque psoriasis. The […]

Alembic Pharma receives USFDA approval for Pregabalin

July 30, 2019 IbisResearch 0

Alembic Pharmaceuticals has received USFDA approval for Pregabalin Capsules, indicated for management of neuropathic pain associated with certain illnesses. The drug is a therapeutically equivalent […]

Alembic Pharma receives USFDA approval for Clonazepam

July 1, 2019 IbisResearch 0

Alembic Pharmaceuticals has received USFDA approval for Clonazepam orally disintegrating tablets which are used for treatment of seizures, adjunct in the treatment of the Lennox-Gastaut […]

Alembic Pharma receives USFDA approval for Bromfenac Ophthalmic Solution

June 26, 2019 IbisResearch 0

Alembic Pharmaceuticals has received USFDA approval from for Bromfenac Ophthalmic Solution, used for treatment of post-operative inflammation and reduction of ocular pain in patients who […]

Alembic Pharma receives USFDA approval for Oseltamivir Phosphate

June 26, 2019 IbisResearch 0

Alembic Pharmaceuticals has received final USFDA approval for Oseltamivir Phosphate capsules, used for treatment of influenza infection. The drug is therapeutically equivalent to the reference […]

Alembic Pharma receives USFDA approval for Solifenacin Succinate

June 20, 2019 IbisResearch 0

Alembic Pharmaceuticals has received USFDA approval for Solifenacin Succinate tablets which are used for treatment of over-active bladder. The product Solifenacin Succinate is a generic […]

Alembic Pharmaceuticals receives USFDA approval for Carbidopa and Levodopa extended-release tablets

June 20, 2019 IbisResearch 0

Alembic Pharmaceuticals has received USFDA approval for Carbidopa and Levodopa extended-release tablets which is used for treatment of Parkinson’s disease. The drug is therapeutically equivalent […]

Alembic Pharma receives USFDA approval for Tadlafil

April 1, 2019 IbisResearch 0

Alembic Pharmaceuticals has received final USFDA approval for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The drug will be marketed in strengths of […]

Posts pagination

1 2 3 »

Segments

Ayurvedic Drugs
BioTechnology
Bulk Drugs
CRAMS
Formulations

India Pharma Directory

Recent Posts

  • CAR-T cell therapy gets commercial approval
  • New Research Centre to be developed in Lavale
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production

Search

About

Ibis Research-which maintains this site - aims to tracks core industrial sectors. It records Indian Pharmaceutical sector news, updates, technology trends, company profiles, updates address directories, tracks new project investments, posting updates on the latest development.

It provides timely information, analysis and insights.

This website tracks state government policies, employment opportunities in the sector, industry climate and economy forecast etc.,

New Projects
  • Maharashtra government plans new bulk drug park in Raigad

    November 21, 2020 0
  • Karnataka government plans new Bio Technology park near Bengaluru

    August 1, 2020 0
  • Desano Pharmaceuticals plans new manufacturing facility in Harohalli

    November 29, 2019 0
  • Union Government to develop a bulk drug park in Himachal Pradesh

    November 26, 2019 0
  • Suven Life Science plans expansion programme

    September 22, 2019 0
Latest News
  • CAR-T cell therapy gets commercial approval
  • New Research Centre to be developed in Lavale
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production

Copyright © 2025 | WordPress Theme by MH Themes